Form 4: UNH Director Gil Granted Shares as Quarterly Compensation

UnitedHealth Group director Kristen Gil received 162 shares of common stock as part of her regular quarterly compensation for board service.

Summary

• Kristen Gil, a Director of UnitedHealth Group Inc. (UNH), acquired 162 shares of common stock.
• The shares were granted as regular quarterly compensation for her service as a director.
• The transaction occurred on October 1, 2025, with a reported acquisition price of $0 per share.
• Following this transaction, Kristen Gil directly owns 1,900 shares of common stock and indirectly owns 3,800 shares through a trust.

Sentiment

Score: 6

Explanation: The filing reports a routine, expected compensation event for a director, which is generally viewed as neutral to slightly positive as it aligns director interests with shareholders. There are no unexpected positive or negative financial implications.

Positives

• The grant of shares as compensation aligns the director's interests with those of shareholders.
• This is a routine compensation practice, indicating stable corporate governance.

Negatives

• No direct negatives are apparent from this routine compensation filing.

Risks

• No specific risks are mentioned in this Form 4 filing.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

The practice of granting equity as compensation to directors is a standard corporate governance practice across various industries, including healthcare, to align leadership incentives with shareholder value creation. This transaction is consistent with typical compensation structures for board members in large public companies.

Comparison to Industry Standards

• Granting equity as part of director compensation is a widely accepted practice among S&P 500 companies, including peers in the managed healthcare sector such as Elevance Health (ELV) and Cigna Group (CI).
• This aligns director interests with long-term shareholder value, a common benchmark for effective corporate governance.

Stakeholder Impact

• Shareholders: Minor positive impact due to increased alignment of director's interests with shareholder value.
• Employees, Customers, Suppliers, Creditors: No direct impact from this routine insider transaction.

Next Steps

• This filing does not mention any specific future actions, events, or milestones.

Key Dates

Keywords

UnitedHealth Group, UNH, Kristen Gil, Director Compensation, Insider Trading, Stock Grant, Form 4, Equity Compensation